Intraoperative ERCP Versus Therapeutic Splitting in Cholecysto-, Choledocholithiasis
NCT ID: NCT06130163
Last Updated: 2025-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2020-01-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis
NCT04213092
Management for Concomitant Gallstones and Common Bile Duct Stones.
NCT04758923
ERCP Plus Laparoscopic Cholecystectomy Versus Laparoscopic Common Bile Duct Exploration and Cholecystectomy
NCT05901363
Post-ERCP Cholecystectomy. How ERCP and ERCP-related Variables Effect the Outcomes?
NCT06388525
Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis
NCT00416234
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to demonstrate and compare the advantages of both procedures at KUK from 1.1.2020 to 30.6.2023 (intraoperative and postoperative ERCP) in terms of morbidity, endoscopic success and the better way for patients and surgeons in clinics.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intraoperative ERCP
Patients with cholecystocholedocholithiasis getting intraoperative ERCP
endoscopic retrograde cholangiopancreatography
endoscopical clearance of the common bile duct
Splitting
Patients with cholecystocholedocholithiasis getting therapeutic splitting
endoscopic retrograde cholangiopancreatography
endoscopical clearance of the common bile duct
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
endoscopic retrograde cholangiopancreatography
endoscopical clearance of the common bile duct
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* emergency or elective
* confirmed choledocholithiasis
* intraoperative ERCP
* preoperative ERCP followed by cholecystectomy
* postoperative ERCP
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kepler University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Sandra Raab
Dr. med. univ.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Shamiyeh, Dr.
Role: STUDY_CHAIR
Kepler University Hospital Linz
Sandra Raab, Dr.
Role: PRINCIPAL_INVESTIGATOR
Kepler University Hospital Linz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Hosital Linz
Linz, Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERCP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.